InspireMD (Boston) said that it has completed enrollment for its Interventional Cardiologists, Interventional Radiologists and Vascular Surgeons (CARENET) trial. The company said that the purpose of the multi-speciality trial is to assess the peri-procedural safety and efficacy of CGuard systems in the treatment of carotid lesions.